Free Trial

Apollomics (APLMW) Competitors

$0.02 +0.01 (+34.00%)
As of 03:48 PM Eastern

APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGW

Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.

Apollomics vs.

Apollomics (NASDAQ:APLMW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Apollomics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ApollomicsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ApollomicsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Apollomics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLMW vs. The Competition

MetricApollomicsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$128.87M$5.36B$8.39B
Dividend YieldN/A3.74%5.22%4.10%
P/E RatioN/A3.4426.5919.72
Price / SalesN/A4,225.38391.61116.20
Price / CashN/A13.1938.2534.62
Price / BookN/A33.126.794.51
Net IncomeN/A-$91.56M$3.23B$248.18M
7 Day PerformanceN/A3.43%4.03%1.14%
1 Month PerformanceN/A7.88%12.22%15.07%
1 Year PerformanceN/A99.78%16.76%6.59%

Apollomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLMW
Apollomics
N/A$0.02
+34.0%
N/A+11.9%$0.00N/A0.0059Gap Down
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
+14.8%
N/A+21.5%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
+2.6%
N/A-52.2%$0.00$607,574.000.002Positive News
DRTSW
Alpha Tau Medical
N/A$0.23
flat
N/A+11.1%$0.00N/A0.0080News Coverage
Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.06
-14.2%
N/A-74.1%$0.00N/A0.008Gap Down
CDIOW
Cardio Diagnostics
N/A$0.02
-5.3%
N/A-75.5%$0.00$34,890.000.007High Trading Volume
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-68.8%$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.04
-14.2%
N/A+108.3%$0.00$48.20M0.00220Positive News
Gap Up
CEROW
CERo Therapeutics
N/A$0.01
-31.5%
N/A-83.0%$0.00N/A0.008Positive News
Gap Down
CINGW
Cingulate
N/A$0.04
-0.3%
N/A+28.0%$0.00N/A0.0020Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:APLMW) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners